INNOVATE Corp. (VATE)
NYSE: VATE
· Real-Time Price · USD
5.82
-0.24 (-3.96%)
At close: May 30, 2025, 3:59 PM
5.78
-0.60%
After-hours: May 30, 2025, 05:48 PM EDT
INNOVATE Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Infrastructure Segment Revenue | 1.07B | 1.4B | 1.59B | 1.16B | 676.6M |
| Infrastructure Segment Revenue Growth | -23.30% | -12.36% | +37.48% | +71.40% | n/a |
| Spectrum Segment Revenue | 25.7M | 22.5M | 38.7M | 42M | 40.3M |
| Spectrum Segment Revenue Growth | +14.22% | -41.86% | -7.86% | +4.22% | n/a |
| Life Sciences Segment Revenue | 9.8M | n/a | n/a | n/a | n/a |
| Life Sciences Segment Revenue Growth | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 |
|---|---|---|---|---|---|---|
| All Other Geographic Locations Revenue | 37.2M | 26.8M | 28.8M | 24.86M | 12.39M | 442.47M |
| All Other Geographic Locations Revenue Growth | +38.81% | -6.95% | +15.87% | +100.60% | -97.20% | n/a |
| United States Revenue | 1.78B | 1.76B | 1.45B | 1.12B | 712.5M | 7.31M |
| United States Revenue Growth | +1.14% | +21.47% | +29.74% | +56.54% | +9642.90% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 37.8M | 41.7M | 37.4M | 42.1M | 39M | 40.2M | 43.8M | 41.1M | 41.7M | 49.8M | 45.6M | 42.1M | 42.6M | 47.4M | 44.3M | 39.5M | 37.1M | 44.5M | 45.2M | 111.1M | 52.3M | 54.9M | 120.5M | 52.1M | 52.9M | 58.4M | 50.9M | 57.05M | 52.09M | 55.96M | 45.36M | 41.71M | 39.86M | 45.4M | 36.9M | 35.61M | 36.3M | 31.17M | 27.83M | 26.48M | 23.05M |
| Selling, General, and Administrative Revenue Growth | -9.35% | +11.50% | -11.16% | +7.95% | -2.99% | -8.22% | +6.57% | -1.44% | -16.27% | +9.21% | +8.31% | -1.17% | -10.13% | +7.00% | +12.15% | +6.47% | -16.63% | -1.55% | -59.32% | +112.43% | -4.74% | -54.44% | +131.29% | -1.51% | -9.42% | +14.74% | -10.79% | +9.54% | -6.92% | +23.38% | +8.75% | +4.64% | -12.21% | +23.02% | +3.62% | -1.90% | +16.47% | +11.99% | +5.11% | +14.85% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.21M | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |